Exposure of Infants to Isoniazid via Breast Milk After Maternal Drug Intake of Recommended Doses Is Clinically Insignificant Irrespective of Metaboliser Status. A Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach to Estimate Drug Exposure of Infants via Breast-Feeding.

PBPK breast milk exposure infants isoniazid pharmacokinetics tuberculosis

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2019
Historique:
received: 11 10 2018
accepted: 04 01 2019
entrez: 7 2 2019
pubmed: 7 2 2019
medline: 7 2 2019
Statut: epublish

Résumé

Isoniazid is a first-line anti-tuberculosis drug recommended for treatment of drug-susceptible

Identifiants

pubmed: 30723406
doi: 10.3389/fphar.2019.00005
pmc: PMC6349757
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5

Références

Toxicol Sci. 2000 Mar;54(1):19-29
pubmed: 10746928
Risk Anal. 2001 Oct;21(5):869-82
pubmed: 11798123
Fundam Clin Pharmacol. 2001 Oct;15(5):355-9
pubmed: 11903505
Environ Health Perspect. 2002 Jun;110(6):A333-7
pubmed: 12055064
Klin Wochenschr. 1953 Jul 1;31(25-26):606-8
pubmed: 13097858
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1953;220(4):321-3
pubmed: 13132954
Rass Clin Ter. 1954 Oct-Dec;53(4):209-14
pubmed: 14372127
Ann ICRP. 2002;32(3-4):5-265
pubmed: 14506981
Pediatrics. 2006 Mar;117(3):e387-95
pubmed: 16510619
Clin Infect Dis. 2006 Apr 1;42(7):1040-7
pubmed: 16511773
Clin Infect Dis. 2007 Sep 15;45(6):715-22
pubmed: 17712755
Toxicol In Vitro. 2008 Mar;22(2):457-67
pubmed: 17981004
Br J Clin Pharmacol. 2008 Mar;65(3):418-22
pubmed: 18093257
Chest. 1991 Feb;99(2):465-71
pubmed: 1824929
Semin Fetal Neonatal Med. 2009 Aug;14(4):234-40
pubmed: 19303830
Environ Health Perspect. 2009 Mar;117(3):481-7
pubmed: 19337526
J Toxicol Environ Health B Crit Rev. 2009;12(5-6):440-72
pubmed: 20183529
Br J Clin Pharmacol. 2011 Jul;72(1):51-62
pubmed: 21320152
J Pharmacokinet Pharmacodyn. 2011 Aug;38(4):405-21
pubmed: 21584718
J Obstet Gynaecol Res. 2012 Sep;38(9):1125-36
pubmed: 22563776
Pharm Res. 1990 Oct;7(10):1077-81
pubmed: 2281040
Toxicol Appl Pharmacol. 2013 Jan 15;266(2):245-53
pubmed: 23142471
Indian J Med Res. 2014 Jul;140(1):32-9
pubmed: 25222775
JAMA Pediatr. 2015 Mar;169(3):247-55
pubmed: 25580725
J Appl Toxicol. 2015 Dec;35(12):1427-32
pubmed: 26095833
J Vet Med. 2015;2015:152730
pubmed: 26464949
J Antimicrob Chemother. 2016 Mar;71(3):703-10
pubmed: 26661397
Br J Clin Pharmacol. 2016 Jun;81(6):1030-6
pubmed: 26773235
Clin Pharmacol Ther. 2016 Jul;100(1):42-52
pubmed: 27060684
Clin Infect Dis. 2016 Oct 1;63(7):e147-e195
pubmed: 27516382
Basic Clin Pharmacol Toxicol. 2018 Aug;123(2):213-220
pubmed: 29505119
Toxicol Lett. 1988 Oct;43(1-3):23-9
pubmed: 3176067
Postgrad Med. 1974 Oct;56(4):97-104
pubmed: 4606454
J Clin Invest. 1966 Nov;45(11):1817-25
pubmed: 5926448
Comput Methods Programs Biomed. 1995 Feb;46(2):155-63
pubmed: 7796584
Eur Respir J. 1996 Oct;9(10):2026-30
pubmed: 8902462

Auteurs

Estella Dora Germaine Garessus (EDG)

Unit Epidemiology, Statistics and Mathematical Modelling, Department Exposure, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Hans Mielke (H)

Unit Epidemiology, Statistics and Mathematical Modelling, Department Exposure, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.

Ursula Gundert-Remy (U)

Unit Epidemiology, Statistics and Mathematical Modelling, Department Exposure, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Institute for Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Berlin Institute of Health, Berlin, Germany.

Classifications MeSH